Elsevier Science, Inc.

SHERPA: Unknown

People

  1. Abou-Alfa
    Abou-Alfa
  2. Capanu
    Capanu
  3. Chou
    Chou
  4. Harding
    Harding
  5. Kalin
    Kalin
  6. Katz
    Katz
  7. Kelsen
    Kelsen
  8. Khalil
    Khalil
  9. Ma
    Ma
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (6)
  2. Gastrointestinal Oncology Service (5)
  3. Solid Tumor Oncology Division (5)
  4. Division of Subspecialty Medicine (2)
  5. Survivorship Research (2)
  6. Biostatistics Service (1)
  7. Body Imaging Service (1)
  8. Center for Pancreatic Cancer Research (1)
  9. Dermatology Service (1)
  10. Dermatology (1)
Search Within
  1. "Journal of Hepatology"
  2. "Department of Medicine"
Formats
  1. Journal Article (4)
  2. Editorial (1)
  3. Review (1)
Groups
  1. Department of Medicine (6)
  2. Gastrointestinal Oncology Service (5)
  3. Solid Tumor Oncology Division (5)
  4. Division of Subspecialty Medicine (2)
  5. Survivorship Research (2)
  6. Biostatistics Service (1)

More Groups

People
  1. Ghassan Abou-Alfa (5)
  2. Bolorsukh Gansukh (1)
  3. Danny Khalil (1)
  4. David Kelsen (1)
  5. Eileen O'Reilly (1)
  6. James Harding (1)

More People

Years
  1. 2023 (1)
  2. 2021 (1)
  3. 2020 (1)
  4. 2016 (1)
  5. 2014 (2)
Publications
  1. Journal of Hepatology (6)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Rational development of combination therapies for biliary tract cancers
    Review

    Harding, J. J.; Khalil, D. N.; Fabris, L.; Abou-Alfa, G. K.
    Journal of Hepatology (2023)

    Fulltext@MSK | Save
  • Decision making in systemic therapy of hepatocellular carcinoma: Should we pay attention to disease aetiology?
    Editorial

    Galle, P. R.; Abou-Alfa, G. K.
    Journal of Hepatology (2021)

    Fulltext@MSK | Save
  • Association of inflammatory biomarkers with clinical outcomes in nivolumab-treated patients with advanced hepatocellular carcinoma
    Journal Article

    Sangro, B.; Melero, I.; Wadhawan, S.; Finn, R. S.; Abou-Alfa, G. K.; Cheng, A. L.; Yau, T.; Furuse, J.; Park, J. W.; Boyd, Z.; more...
    Journal of Hepatology (2020)

    Fulltext@MSK | Save
  • Randomized phase II placebo controlled study of codrituzumab in previously treated patients with advanced hepatocellular carcinoma
    Journal Article

    Abou-Alfa, G. K.; Puig, O.; Daniele, B.; Kudo, M.; Merle, P.; Park, J. W.; Ross, P.; Peron, J. M.; Ebert, O.; Chan, S.; more...
    Journal of Hepatology (2016)

    Fulltext@MSK | Save
  • Prospective randomized pilot study of Y90 +/- sorafenib as bridge to transplantation in hepatocellular carcinoma
    Journal Article

    Kulik, L.; Vouche, M.; Koppe, S.; Lewandowski, R. J.; Mulcahy, M. F.; Ganger, D.; Habib, A.; Karp, J.; Al-Saden, P.; Lacouture, M.; more...
    Journal of Hepatology (2014)

    Fulltext@MSK | Save
  • A phase II study of cixutumumab (IMC-A12, NSC742460) in advanced hepatocellular carcinoma
    Journal Article

    Abou-Alfa, G. K.; Capanu, M.; O'Reilly, E. M.; Ma, J.; Chou, J. F.; Gansukh, B.; Shia, J.; Kalin, M.; Katz, S.; Abad, L.; more...
    Journal of Hepatology (2014)

    Fulltext@MSK | Save